Key result
Percutaneous balloon valvotomy avoids surgery in ~58% of infants, linked to larger tricuspid valve annulus.
Why the study?
The follow-up and determinants of success of percutaneous balloon valvotomy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum are limited.
What are the anatomic and hemodynamic determinants of successful percutaneous balloon valvotomy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum?
Observational (n=12)
What are the anatomic and hemodynamic determinants of successful percutaneous balloon valvotomy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum?
Answers are grounded in this paper and cite their sources.
Percutaneous balloon valvotomy is effective and provides definitive therapy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum who have adequate tricuspid and pulmonary valve annuli and right ventricular volume.
OBJECTIVES: This study reviewed our experience with percutaneous balloon valvotomy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum and defined the anatomic and hemodynamic characteristics of infants in whom this procedure is successful and provides definitive therapy. BACKGROUND: Unlike children with valvular pulmonary stenosis, the follow-up of infants with critical pulmonary stenosis undergoing percutaneous balloon valvotomy is limited. METHODS: Between December 1987 and August 1992, percutaneous balloon valvotomy was attempted in 12 infants with critical pulmonary stenosis (n = 10) or pulmonary atresia with intact ventricular septum (n = 2). Two outcome groups were identified: Group A patients are acyanotic, have mild residual pulmonary stenosis and have not required operation; Group B patients have required operation. RESULTS: Of the 12 infants, 11 had a successful balloon valvotomy procedure. Group A patients (n = 7) have a residual gradient of 22 +/- 18.7 mm Hg (mean +/- SD) at follow-up of 3.2 years (range 1.2 to 5.0). In Group B (n = 5), operation was required for inability to cross the pulmonary valve (n = 1) or persistent severe hypoxemia for > or = 2 weeks after valvotomy (n = 4). Significant differences (p < or = 0.01) between the two groups (Group A vs. Group B) were identified in pulmonary valve annulus (Z value) 8.1 mm (-1.1) versus 5.5 mm (-3.4); tricuspid valve annulus (Z value) 14.0 mm (0.8) versus 8.8 mm (-1.8); right ventricular volume 65 versus 29 ml/m2; and Lewis index 10.9 versus 8.9. CONCLUSIONS: Percutaneous balloon valvotomy is effective and likely to provide definitive therapy in infants with critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum who have a tricuspid valve annulus > 11 mm, pulmonary valve annulus > or = 7 mm and right ventricular volume > 30 ml/m2.
No takes yet. Share an insight, caveat, or question.
Fedderly et al. (1995) conducted an observational in Critical pulmonary stenosis or membranous pulmonary atresia with intact ventricular septum (n=12). Percutaneous balloon valvotomy was evaluated on Requirement for subsequent operation (p=<=0.01). Percutaneous balloon valvotomy provided definitive therapy without surgery in 7 of 12 infants, with success linked to a larger tricuspid valve annulus.
Synapse has enriched 10 related papers. Consider them for comparative context: